214 related articles for article (PubMed ID: 34234013)
1. Design and proof of concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Staquicini DI; Tang FHF; Markosian C; Yao VJ; Staquicini FI; Dodero-Rojas E; Contessoto VG; Davis D; O'Brien P; Habib N; Smith TL; Bruiners N; Sidman RL; Gennaro ML; Lattime EC; Libutti SK; Whitford PC; Burley SK; Onuchic JN; Arap W; Pasqualini R
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34234013
[TBL] [Abstract][Full Text] [Related]
2. Design and proof-of-concept for targeted phage-based COVID-19 vaccination strategies with a streamlined cold-free supply chain.
Staquicini DI; Tang FHF; Markosian C; Yao VJ; Staquicini FI; Dodero-Rojas E; Contessoto VG; Davis D; O'Brien P; Habib N; Smith TL; Bruiners N; Sidman RL; Gennaro ML; Lattime EC; Libutti SK; Whitford PC; Burley SK; Onuchic JN; Arap W; Pasqualini R
bioRxiv; 2021 Mar; ():. PubMed ID: 33758865
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
4. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
5. Next-generation of targeted AAVP vectors for systemic transgene delivery against cancer.
Suwan K; Yata T; Waramit S; Przystal JM; Stoneham CA; Bentayebi K; Asavarut P; Chongchai A; Pothachareon P; Lee KY; Topanurak S; Smith TL; Gelovani JG; Sidman RL; Pasqualini R; Arap W; Hajitou A
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18571-18577. PubMed ID: 31375630
[TBL] [Abstract][Full Text] [Related]
6. Targeted systemic gene therapy and molecular imaging of cancer contribution of the vascular-targeted AAVP vector.
Hajitou A
Adv Genet; 2010; 69():65-82. PubMed ID: 20807602
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylation and DNA methylation improves gene expression mediated by the adeno-associated virus/phage in cancer cells.
Kia A; Yata T; Hajji N; Hajitou A
Viruses; 2013 Oct; 5(10):2561-72. PubMed ID: 24153059
[TBL] [Abstract][Full Text] [Related]
9. An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates.
Zabaleta N; Dai W; Bhatt U; Hérate C; Maisonnasse P; Chichester JA; Sanmiguel J; Estelien R; Michalson KT; Diop C; Maciorowski D; Dereuddre-Bosquet N; Cavarelli M; Gallouët AS; Naninck T; Kahlaoui N; Lemaitre J; Qi W; Hudspeth E; Cucalon A; Dyer CD; Pampena MB; Knox JJ; LaRocque RC; Charles RC; Li D; Kim M; Sheridan A; Storm N; Johnson RI; Feldman J; Hauser BM; Contreras V; Marlin R; Tsong Fang RH; Chapon C; van der Werf S; Zinn E; Ryan A; Kobayashi DT; Chauhan R; McGlynn M; Ryan ET; Schmidt AG; Price B; Honko A; Griffiths A; Yaghmour S; Hodge R; Betts MR; Freeman MW; Wilson JM; Le Grand R; Vandenberghe LH
Cell Host Microbe; 2021 Sep; 29(9):1437-1453.e8. PubMed ID: 34428428
[TBL] [Abstract][Full Text] [Related]
10. A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.
He X; Ding L; Cao K; Peng H; Gu C; Li Y; Li D; Dong L; Hong X; Wang X; Fu M; Qiu C; Zhu C; Zhang Z; Song S; Wang C; Jiang Z; Xie Y; Qi Z; Zhao C; Zhao P; Zhang X; Xu J
Emerg Microbes Infect; 2021 Dec; 10(1):1555-1573. PubMed ID: 34304724
[TBL] [Abstract][Full Text] [Related]
11. Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 Infection.
Li M; Guo J; Lu S; Zhou R; Shi H; Shi X; Cheng L; Liang Q; Liu H; Wang P; Wang N; Wang Y; Fu L; Xing M; Wang R; Ju B; Liu L; Lau SY; Jia W; Tong X; Yuan L; Guo Y; Qi H; Zhang Q; Huang Z; Chen H; Zhang Z; Chen Z; Peng X; Zhou D; Zhang L
Front Immunol; 2021; 12():697074. PubMed ID: 34262569
[TBL] [Abstract][Full Text] [Related]
12. The Breadth of Bacteriophages Contributing to the Development of the Phage-Based Vaccines for COVID-19: An Ideal Platform to Design the Multiplex Vaccine.
Ul Haq I; Krukiewicz K; Yahya G; Haq MU; Maryam S; Mosbah RA; Saber S; Alrouji M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675046
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma.
Przystal JM; Waramit S; Pranjol MZI; Yan W; Chu G; Chongchai A; Samarth G; Olaciregui NG; Tabatabai G; Carcaboso AM; Aboagye EO; Suwan K; Hajitou A
EMBO Mol Med; 2019 Apr; 11(4):. PubMed ID: 30808679
[TBL] [Abstract][Full Text] [Related]
14. Design and construction of targeted AAVP vectors for mammalian cell transduction.
Hajitou A; Rangel R; Trepel M; Soghomonyan S; Gelovani JG; Alauddin MM; Pasqualini R; Arap W
Nat Protoc; 2007; 2(3):523-31. PubMed ID: 17406616
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract.
Jearanaiwitayakul T; Apichirapokey S; Chawengkirttikul R; Limthongkul J; Seesen M; Jakaew P; Trisiriwanich S; Sapsutthipas S; Sunintaboon P; Ubol S
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835008
[TBL] [Abstract][Full Text] [Related]
16. The natural dietary genistein boosts bacteriophage-mediated cancer cell killing by improving phage-targeted tumor cell transduction.
Tsafa E; Al-Bahrani M; Bentayebi K; Przystal J; Suwan K; Hajitou A
Oncotarget; 2016 Aug; 7(32):52135-52149. PubMed ID: 27437775
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome-coronavirus-2 spike (S) protein based vaccine candidates: State of the art and future prospects.
Arashkia A; Jalilvand S; Mohajel N; Afchangi A; Azadmanesh K; Salehi-Vaziri M; Fazlalipour M; Pouriayevali MH; Jalali T; Mousavi Nasab SD; Roohvand F; Shoja Z;
Rev Med Virol; 2021 May; 31(3):e2183. PubMed ID: 33594794
[TBL] [Abstract][Full Text] [Related]
19. One dose of COVID-19 nanoparticle vaccine REVC-128 protects against SARS-CoV-2 challenge at two weeks post-immunization.
Gu M; Torres JL; Li Y; Van Ry A; Greenhouse J; Wallace S; Chiang CI; Pessaint L; Jackson AM; Porto M; Kar S; Li Y; Ward AB; Wang Y
Emerg Microbes Infect; 2021 Dec; 10(1):2016-2029. PubMed ID: 34651563
[No Abstract] [Full Text] [Related]
20. Doxorubicin Improves Cancer Cell Targeting by Filamentous Phage Gene Delivery Vectors.
Tsafa E; Bentayebi K; Topanurak S; Yata T; Przystal J; Fongmoon D; Hajji N; Waramit S; Suwan K; Hajitou A
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
